Alkeran
In the US, Alkeran (melphalan systemic) is a member of the drug class alkylating agents and is used to treat Multiple Myeloma and Ovarian Cancer.
US matches:
Ingredient matches for Alkeran
Melphalan is reported as an ingredient of Alkeran in the following countries:
- Australia
- Austria
- Bahrain
- Belgium
- Brazil
- Canada
- China
- Czech Republic
- Denmark
- Egypt
- Ethiopia
- Finland
- Germany
- Greece
- Hong Kong
- Iceland
- India
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Jordan
- Kenya
- Kuwait
- Latvia
- Lebanon
- Lithuania
- Luxembourg
- Malaysia
- Mexico
- Netherlands
- New Zealand
- Norway
- Oman
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russian Federation
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Sweden
- Switzerland
- Syria
- Taiwan
- Thailand
- Turkey
- United Arab Emirates
- United Kingdom
- United States
- Yemen
Melphalan hydrochloride (a derivative of Melphalan) is reported as an ingredient of Alkeran in the following countries:
- Chile
- Lithuania
- Sweden
- United Kingdom
- United States
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
